Restricted accessResearch articleFirst published online 2021-12
Anti–Interleukin 23–Based Therapies May Shift Cutaneous Immune Responses: A Case of New-Onset Contact Dermatitis to Carbamates after Guselkumab for Psoriasis
MerleevAA, MarusinaAI, MaC, et al.Meta-analysis of RNA sequencing datasets reveals an association between TRAJ23, psoriasis, and IL-17A. JCI Insight, 2018; 3(13):.
2.
EberleFC, BrückJ, HolsteinJ, et al.Recent advances in understanding psoriasis. F1000Res, 2016; 5:F1000 Faculty Rev-1770.
3.
RiemannH, SchwarzA, GrabbeS, et al.Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol, 1996; 156(5):1799–.
4.
AntoniosD, RousseauP, LarangéA, et al.Mechanisms of IL-12 synthesis by human dendritic cells treated with the chemical sensitizer NiSO4. J Immunol, 2010; 185(1):89–98.
5.
SieveAN, MeeksKD, LeeS, et al.A novel immunoregulatory function for IL-23: inhibition of IL-12–dependent IFN-γ production. Eur J Immunol, 2010; 40(8):2236–2247.
6.
TruongA, LeS, KiuruM, et al.Nummular dermatitis on guselkumab for palmoplantar psoriasis. Dermatol Ther, 2019; 32(4):e12954.